Dachaigh › Luchd-obrach › Sanofi-Aventis US LLC
Sanofi-Aventis US LLC: Tuarastalan H-1B agus taic bhìosa
Chuir Sanofi-Aventis US LLC 20 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 18. Tuarastal meadhanach a chaidh a thabhann: $153,046.
A bheil Sanofi-Aventis US LLC a’ toirt taic do bhìosaichean H-1B?
Chuir Sanofi-Aventis US LLC 20 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 16 Gibl 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Senior Director, Insights and Analytics (RSV) | 2 | — |
| Senior Manager, Pharmaceutical Development & Quality | 1 | $116,156 |
| Associate Director, Access Analytics | 1 | $163,238 |
| Manager, Digital Marketing | 1 | $119,687 |
| Manager, Access Analytics | 1 | — |
| Associate Director, Field Reporting Governance | 1 | $123,750 |
| Associate Director, Brand Analytics Rare Disease | 1 | $123,750 |
| Director - Field Platforms CRM Operations | 1 | $153,046 |
| Sr. Manager, Pharmaceutical Development & Quality | 1 | $122,250 |
| Associate Director, Brand Analytics Rare Blood Disorders | 1 | $170,373 |
| Associate Director, CRM Enhancement Management | 1 | $153,046 |
| Director, Field Deployment and Incentive Comp. - Vaccine | 1 | $179,211 |
| Associate Director, NA Omnichannel Media Analytics Lead | 1 | $170,373 |
| Associate Director, Advanced Analytics - NA Omnichannel | 1 | $148,762 |
| Associate Director, Field Deployment and Incentives | 1 | $159,682 |
| Associate Director, Field Reporting | 1 | $156,645 |
| Senior Director, Insights and Analytics (Pediatric Vaccines) | 1 | $177,000 |
| Associate Director | 1 | $156,894 |
| Associate Director, Brand Analytics, Transplant | 1 | $148,500 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2024 | 3 | $117,922 |
| FY2025 | 11 | $153,046 |
| FY2026 | 6 | $160,066 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Data Scientists9
- Industrial Engineers2
- Marketing Managers2
- Computer Systems Engineers/Architects2
- Management Analysts2
- Operations Research Analysts1
- General and Operations Managers1
- Market Research Analysts and Marketing Specialists1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Associate Director, Brand Analytics, Transplant | $148,500–$247,500 Ìre IV | Morristown, NJ | 16 Gibl 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Associate Director | $156,894–$205,000 Ìre II | Morristown, NJ | 26 Faoi 2026 | 30 Faoi 2026 | Dearbhaichte |
| Senior Director, Insights and Analytics (Pediatric Vaccines) | $177,000–$295,000 Ìre IV | Morristown, NJ | 13 Samh 2025 | 17 Samh 2025 | Dearbhaichte |
| Senior Director, Insights and Analytics (RSV) | $177,000–$295,000 Ìre IV | Morristown, NJ | 11 Samh 2025 | 17 Samh 2025 | Air a tharraing air ais |
| Senior Director, Insights and Analytics (RSV) | $177,000–$295,000 Ìre IV | Morristown, NJ | 7 Samh 2025 | 17 Samh 2025 | Air a tharraing air ais |
| Associate Director, Field Reporting | $156,645–$208,750 Ìre IV | Morristown, NJ | 28 Lùna 2025 | 15 Sult 2025 | Dearbhaichte |
| Associate Director, NA Omnichannel Media Analytics Lead | $170,373–$245,000 Ìre IV | Cambridge, MA | 20 Cèit 2025 | 8 Ògmh 2025 | Dearbhaichte |
| Associate Director, Advanced Analytics - NA Omnichannel | $148,762–$208,750 Ìre IV | Cambridge, MA | 21 Gibl 2025 | 29 Gibl 2025 | Dearbhaichte |
| Associate Director, Field Deployment and Incentives | $159,682–$208,750 Ìre IV | Morristown, NJ | 18 Gibl 2025 | 28 Gibl 2025 | Dearbhaichte |
| Associate Director, Brand Analytics Rare Blood Disorders | $170,373–$208,750 Ìre IV | Bridgewater, NJ | 7 Màrt 2025 | 17 Màrt 2025 | Dearbhaichte |
| Associate Director, CRM Enhancement Management | $153,046–$206,250 Ìre IV | Bridgewater, NJ | 17 Faoi 2025 | 3 Gearr 2025 | Dearbhaichte |
| Director, Field Deployment and Incentive Comp. - Vaccine | $179,211–$246,875 | Bridgewater, NJ | 31 Dùbh 2024 | 6 Faoi 2025 | Dearbhaichte |
| Associate Director, Field Reporting Governance | $123,750–$206,500 Ìre II | Cambridge, MA | 18 Dùbh 2024 | 5 Faoi 2025 | Dearbhaichte |
| Associate Director, Brand Analytics Rare Disease | $123,750–$206,250 Ìre I | Cambridge, MA | 21 Samh 2024 | 2 Dùbh 2024 | Dearbhaichte |
| Director - Field Platforms CRM Operations | $153,046–$246,875 Ìre IV | Bridgewater, NJ | 13 Samh 2024 | 25 Samh 2024 | Dearbhaichte |
| Sr. Manager, Pharmaceutical Development & Quality | $122,250–$203,750 Ìre III | Bridgewater, NJ | 30 Dàmh 2024 | 19 Gibl 2025 | Dearbhaichte |
| Manager, Access Analytics | — Ìre II | Bridgewater, NJ | 3 Cèit 2024 | 1 Dàmh 2024 | Dearbhaichte |
| Senior Manager, Pharmaceutical Development & Quality | $116,156–$193,593 Ìre III | Bridgewater, NJ | 10 Samh 2023 | 29 Dùbh 2023 | Dearbhaichte |
| Associate Director, Access Analytics | $163,238–$225,859 Ìre IV | Cambridge, MA | 27 Dàmh 2023 | 1 Samh 2023 | Dearbhaichte, an uair sin air a tharraing air ais |
| Manager, Digital Marketing | $119,687–$195,000 | Bridgewater, NJ | 16 Ògmh 2021 | 1 Dàmh 2021 | Dearbhaichte, an uair sin air a tharraing air ais |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).